Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.63% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 1.29% |
| 4 | Communication Services | 0.93% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APEN
10651
DELISTED
Apollo Endosurgery, Inc.
APEN
| $285K | ﹤0.01% |
+31,418
| New | +$270K |
|
10652
Alzamend Neuro
ALZN
$8.01M
| $284K | ﹤0.01% |
68
+26
| +62% | +$143K |
|
10653
PUT
Cavco Industries
CVCO
$4.37B
| $284K | ﹤0.01% |
1,200
-2,500
| -68% | -$601K |
|
|
FDIQ
10654
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$44.3M
| $284K | ﹤0.01% |
4,618
-13,147
| -74% | -$769K |
|
10655
Gentherm
THRM
$1.21B
| $284K | ﹤0.01% |
3,504
-5,669
| -62% | -$449K |
|
10656
Weyco Group
WEYS
$434M
| $284K | ﹤0.01% |
+12,516
| New | +$288K |
|
10657
PUT
Entera Bio
ENTX
$525M
| $283K | ﹤0.01% |
60,100
-32,000
| -35% | -$164K |
|
10658
PUT
Mueller Water Products
MWA
$3.81B
| $283K | ﹤0.01% |
+18,600
| New | +$286K |
|
10659
Noodles & Co
NDLS
$88.2M
| $283K | ﹤0.01% |
+2,998
| New | +$293K |
|
10660
PUT
POSCO
PKX
$18.2B
| $283K | ﹤0.01% |
4,100
-4,500
| -52% | -$332K |
|
|
REVG
10661
CALL
DELISTED
REV Group
REVG
| $283K | ﹤0.01% |
16,500
-1,800
| -10% | -$28.7K |
|
10662
PUT
Smart Sand
SND
$220M
| $283K | ﹤0.01% |
115,600
+27,600
| +31% | +$70.7K |
|
10663
CALL
Viridian Therapeutics
VRDN
$2.61B
| $283K | ﹤0.01% |
+17,200
| New | +$252K |
|
10664
PUT
Future FinTech Group
FTFT
$4.48M
| $282K | ﹤0.01% |
169
+18
| +12% | +$36.3K |
|
10665
Landstar System
LSTR
$6.11B
| $282K | ﹤0.01% |
1,784
-3,983
| -69% | -$636K |
|
10666
Marcus Corp
MCS
$895M
| $282K | ﹤0.01% |
16,137
-6,796
| -30% | -$111K |
|
10667
PUT
Puma Biotechnology
PBYI
$468M
| $282K | ﹤0.01% |
40,200
+1,500
| +4% | +$11.2K |
|
10668
Riverview Bancorp
RVSB
$103M
| $282K | ﹤0.01% |
+38,812
| New | +$279K |
|
10669
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.6B
| $282K | ﹤0.01% |
6,115
-74,670
| -92% | -$3.53M |
|
10670
PUT
Vanguard Communication Services ETF
VOX
$5.88B
| $282K | ﹤0.01% |
2,000
-900
| -31% | -$131K |
|
|
AAMI
10671
PUT
Acadian Asset Management
AAMI
$3.4B
| $282K | ﹤0.01% |
10,800
-2,700
| -20% | -$69.5K |
|
|
BIOR
10672
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $282K | ﹤0.01% |
742
+312
| +73% | +$134K |
|
10673
Belden
BDC
$4.5B
| $281K | ﹤0.01% |
4,815
-93,308
| -95% | -$5M |
|
|
KZIA
10674
Kazia Therapeutics
KZIA
$155M
| $281K | ﹤0.01% |
490
+204
| +71% | +$100K |
|
10675
CALL
Wintrust Financial
WTFC
$10.3B
| $281K | ﹤0.01% |
3,500
-14,700
| -81% | -$1.09M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.